25 Jun 2026
- Year 1 volume target ~8 million units; year 2 target 13-15 million units
- Margins expected at industry standard 1.5-2% EBITDA initially, improving with scale and value addition
- Trial production to start Q4 FY27; commercial production from Q1 FY28